The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 39837736.
- Also identified by DOI 10.1016/j.eururo.2025.01.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Co-IMPACT consortium addresses knowledge gaps in prostate-specific membrane antigen positron emission tomography-guided radiotherapy for prostate cancer by establishing a global database (46 centres from 16 countries) to standardise and analyse data across four distinguished clinical scenarios. A collaborative model with the Advanced Prostate Cancer Consensus Conference aligns urgent clinical needs with actionable research insights.
Medical subject headings
- Prostatic Neoplasms
- Positron-Emission Tomography
- Glutamate Carboxypeptidase II
- Antigens, Surface
- Radiotherapy, Image-Guided